Syverson Strege & Co

SEC CIK: 0001682057
Latest filing: Aug 6, 2026

SEC filings (opens in a new tab)

ABT holding history

Abbott Laboratories in every 13F filed by Syverson Strege & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overview All 13F holders of ABT Full Q2 2026 holdings

Shares (Q2 2026): 12,020
Value: $1.09M
% of portfolio: 0.2%
Quarters held: 20; Since Q1 2021

Holdings of ABT by Syverson Strege & Co, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	12,020	$1.09M	0.2%	−2,135−15.1%	Reduced	Holders
Q1 2026	14,155	$1.45M	0.3%	−379−2.6%	Reduced	Holders
Q4 2025	14,534	$1.82M	0.4%	+2,617+22.0%	Added	Holders
Q3 2025	11,917	$1.60M	0.4%	−157−1.3%	Reduced	Holders
Q2 2025	12,074	$1.64M	0.4%	+2,723+29.1%	Added	Holders
Q1 2025	9,351	$1.24M	0.4%	+41+0.4%	Added	Holders
Q4 2024	9,310	$1.05M	0.4%	+1,124+13.7%	Added	Holders
Q3 2024	8,186	$933.3K	0.3%	−1,597−16.3%	Reduced	Holders
Q2 2024	9,783	$1.02M	0.3%	+7,520+332.3%	Added	Holders
Q1 2024	2,263	$257.2K	0.1%	+244+12.1%	Added	Holders
Q4 2023	2,019	$222.2K	0.1%	+2,019	New	Holders
Q2 2023	0	$0	0.0%	−1,805−100.0%	Sold out	Holders
Q1 2023	1,805	$182.8K	0.1%	+7+0.4%	Added	Holders
Q4 2022	1,798	$197.5K	0.1%	+6+0.3%	Added	Holders
Q3 2022	1,792	$173.0K	0.1%	+6+0.3%	Added	Holders
Q2 2022	1,786	$194.0K	0.1%	+5+0.3%	Added	Holders
Q1 2022	1,781	$211.0K	0.2%	+6+0.3%	Added	Holders
Q4 2021	1,775	$250.0K	0.2%	−25−1.4%	Reduced	Holders
Q3 2021	1,800	$213.0K	0.2%	−462−20.4%	Reduced	Holders
Q2 2021	2,262	$262.0K	0.2%	−354−13.5%	Reduced	Holders
Q1 2021	2,616	$314.0K	0.3%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.